Finance

Lists
Why is ALZN up 8.26%?
Dive Deeper
ALZN:NASDAQ
Alzamend Neuro Inc
$1.31
+8.26%
(+0.100) 1D
$1.24
-5.57% (-0.073)
Pre-market
Closed: Nov 2, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALZN...
Open
$1.32
High
$1.33
Low
$1.21
Mkt. cap
6.32M
Avg. vol.
47.16K
Volume
0.00
52-wk high
$2.61
52-wk low
$0.85
EPS
-$2.27
Beta
0.27
Shares outstanding
4.83M
No. of employees
5
Open
$1.32
High
$1.33
Low
$1.21
Mkt. cap
6.32M
Avg. vol.
47.16K
Volume
0.00
52-wk high
$2.61
52-wk low
$0.85
EPS
-$2.27
Beta
0.27
Shares outstanding
4.83M
No. of employees
5
News stories
From web sources and news partners
About Alzamend Neuro Inc
CEO-
Employees5
Founded2016
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitealzamend.com
Analyst ratings
Based on 1 analyst giving stock ratings to ALZN in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ALZN in the last 3 months
Highest
Current $1.31
$26.00 (+1,884.73%)
Average
$26.00 (+1,884.73%)
Lowest
$26.00 (+1,884.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
$26.00
+1,884.7%
08/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
176.28K
1.28M
434.01K
1.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
821.83K
919.02K
2.44M
1.94M
Operating expense
998.11K
2.20M
2.87M
3.03M
Total operating expenses
998.11K
2.20M
2.87M
3.03M
Operating income
-998.11K
-2.20M
-2.87M
-3.03M
Other non operating income
-
-
-
-
EBT including unusual items
-1.00M
-2.20M
-2.87M
-3.03M
EBT excluding unusual items
-1.00M
-2.20M
-2.87M
-3.03M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.00M
-2.20M
-2.87M
-3.03M
Net profit margin
-
-
-
-
Earnings per share
-0.30
-0.58
-0.74
-0.68
Interest and investment income
-
-
1.08K
399.00
Interest expense
-2.65K
-1.34K
-150.00
-2.00K
Net interest expenses
-2.65K
-1.34K
928.00
-1.61K
Depreciation and amortization charges
-
-
-
-
EBITDA
-970.42K
-2.17M
-2.84M
-3.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps